Aimei Health Technology Co., Ltd Unit
AFJKU
NASDAQ Global Market16.58
USD
-0.66
- -
CIK
0001979005
ISIN
KYG013411171
CUSIP
G01341117
Return %
Stock
S&P500
1Y
47.38
18.21
3Y
63.35
64.38
5Y
63.35
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Junheng Xie
- Full Time Employees
- 2
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 10 East 53rd Street New York City NY United States of America
- IPO Date
- Dec 4, 2023
- CIK
- 0001979005
- Website
- aimeihealth.com
- Similar Companies
- Business
- Aimei Health Technology Co., Ltd (AFJKU) is a blank check company incorporated in the Cayman Islands that seeks to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses focused on healthcare innovation, including biopharmaceuticals, medical technology, medical devices, diagnostics, and related services; it targets small-cap companies in North America, Europe, and Asia Pacific regions, excluding principal operations in China, Hong Kong, or Macau. The company offers no current products or services, generating income solely from interest on its trust account cash holdings following its initial public offering. Founded in 2023 and headquartered at 10 East 53rd Street, Suite 3001, New York, NY 10022, Aimei operates in the diversified financial services industry with zero employees and no geographic operations beyond its pursuit of a target acquisition. In recent developments, the company completed a $60 million IPO of 6 million units at $10 each on December 6, 2023, listed on Nasdaq; entered into a definitive business combination agreement on June 19, 2024—as amended June 6, 2025—with United Hydrogen Group Inc., a Cayman Islands exempted company, involving mergers through wholly-owned subsidiaries United Hydrogen Global Inc., United Hydrogen Victor Limited, and United Hydrogen Worldwide Limited; secured shareholder approval for the transaction on November 6, 2025; and extended its combination deadline multiple times, most recently to December 6, 2025, via unsecured promissory notes totaling over $1.6 million from sponsor Aimei Investment Ltd. and United Hydrogen, including a $150,000 deposit in October 2025, while facing substantial going-concern doubt due to heavy redemptions reducing trust assets to $45.4 million as of September 30, 2025. The proposed merger positions Aimei to acquire United Hydrogen's operations upon closing, expected in early 2026 subject to regulatory clearances and conditions, with no revenues or net operating income reported in its latest quarterly filing.
AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: ATMCR, CRTAF, LPAA, and AFJKU
United Hydrogen Group Inc., a Comprehensive Hydrogen Solution Company in China, Announces Execution of Business Combination Agreement with Aimei Health Technology Co., Ltd to Become a Publicly Traded Company on Nasdaq
Aimei Health Technology Co., Ltd. Announces the Separate Trading of its Ordinary Shares and Rights Commencing January 22, 2024
Aimei Health Technology Co., Ltd Announces Closing of $69 Million Initial Public Offering
Aimei Health Technology Co., Ltd Announces Pricing of $60 Million Initial Public Offering